Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
10/07/1998 | EP0605701B1 Cytodiagnosis method using alstonine as a selective marker, and diagnostic kit containing said marker |
10/06/1998 | US5817873 Polyiodinated compounds, their preparation and their use as contrast media for radiology |
10/06/1998 | US5817861 Process for the preparation of an intermediate useful in the synthesis of iodinated contrast media |
10/06/1998 | US5817632 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
10/06/1998 | US5817292 MR imaging compositions and methods |
10/06/1998 | US5817291 Method of ultrasonic imaging comprising administering biocompatible spheres or particles |
10/06/1998 | US5817290 Method of and test kit for mutagenesis testing |
10/06/1998 | US5817289 Non-cluster type bismuth compounds |
10/06/1998 | US5817028 Method and device for the provocation of air passage narrowing and/or the induction of sputum |
10/06/1998 | CA1340071C Dectection of infectious and inflammatory lesions using anti-leukocyte conjugates |
10/01/1998 | WO1998042826A1 Tissue specific promoters |
10/01/1998 | WO1998042825A1 A transgenic model of colon cancer and anal cancer |
10/01/1998 | WO1998042735A1 Novel monomer elements for marking peptidic nucleic acids |
10/01/1998 | WO1998042384A1 Methods for delivering bioactive agents |
10/01/1998 | WO1998042383A1 Charged lipids and uses for the same |
10/01/1998 | WO1998020904A3 Microparticles filled with liquid acting according to a new principle and their use as diagnostic and therapeutic agents |
10/01/1998 | DE19712530A1 Neue Monomerbausteine zur Markierung von peptidischen Nukleinsäuren New monomer to mark peptide nucleic acids |
10/01/1998 | CA2285413A1 Tissue specific promoters |
10/01/1998 | CA2284735A1 A transgenic model of colon cancer and anal cancer |
09/30/1998 | EP0867729A1 Overhauser enhanced magnetic resonance imaging technique (OMRI or REDRI or ESREMPI) |
09/30/1998 | EP0866723A2 Use of gaseous metallic complexes as ultrasound contrasting agents |
09/30/1998 | EP0866655A2 Murine model for human carcinoma |
09/30/1998 | EP0659056B1 Artifact-free imaging contrast agent |
09/30/1998 | CN1194161A Preparing liquid for producing ultrasonic diagnostic contrast medium and the method of preparing contrast medium therewith |
09/29/1998 | US5814599 Applying a patch to the skin which delivers therapeutic dosages |
09/29/1998 | US5814317 Structural alterations of the EGF receptor gene in human gliomas |
09/29/1998 | US5814301 Contrast agents for medical diagnosis of cardiovascular disorders |
09/29/1998 | US5814300 Gene-targeted non-human mammals deficient in the SOD-1 gene |
09/24/1998 | WO1998041540A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy |
09/24/1998 | WO1998041241A1 Mri contrast media recognizing minor environmental changes |
09/24/1998 | WO1998041239A1 Compositions comprising flexible particles, non-ionic surfactant and non-ionic cloud-point modifier |
09/24/1998 | CA2284581A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy |
09/24/1998 | CA2284205A1 Mri contrast media recognizing microenvironmental changes |
09/23/1998 | EP0865785A2 Antimicrobial caries-detecting composition |
09/23/1998 | EP0734268A4 Xenogeneic tissue implant in ear pinna |
09/23/1998 | CN1193952A Heterocyclic methyl free radicals as image enhancing agents |
09/23/1998 | CN1193625A Polyazamacrocyclic compounds of complexation of metal ions |
09/22/1998 | US5811581 Process for the purification of opacifying contrast agents |
09/22/1998 | US5811449 Administering a suppressor pyrrolidine dithiocarbamate to prevent the oxidation of a polyunsaturated fatty acid |
09/22/1998 | US5811405 Pharmaceuticals, diagnostic agents |
09/22/1998 | US5811237 Sequence coding for protein expressed by campylobacter pylori |
09/22/1998 | US5811077 Method of NMR imaging |
09/22/1998 | US5811076 Macromolecular contrast media for MR imaging |
09/22/1998 | US5811005 Apparatus for intravenous administration of solutions of cell-free hemoglobin including a nitroxide bound to a matrix |
09/22/1998 | US5809801 Cryogenic accumulator for spin-polarized xenon-129 |
09/22/1998 | CA2050679C Preparation of liposome and lipid complex compositions |
09/17/1998 | WO1998040502A1 Peptide-enhanced transfections |
09/17/1998 | WO1998040497A2 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
09/17/1998 | WO1998040106A1 Method of measuring physiological function |
09/17/1998 | WO1998040052A1 Cationic lipid compositions targeting angiogenic endothelial cells |
09/17/1998 | WO1998040049A2 Specific magnetosome, method for the production and use thereof |
09/17/1998 | WO1998029565A3 Novel method for testing the differentiation status in pancreatic cells of a mammal |
09/17/1998 | DE19716732A1 Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung Specific magnetosomes, processes for their preparation and their use |
09/17/1998 | DE19706490C1 Verfahren zur Herstellung von Säureamiden und zur Metallierung von Verbindungen und Verwendung der nach den Verfahren hergestellten Verbindungen Process for the preparation of acid amides and the metalation of compounds and use of the compounds prepared by the processes |
09/16/1998 | EP0863885A2 Novel macrocyclic compounds as metalloprotease inhibitors |
09/16/1998 | EP0863770A1 Contrast medium and its use |
09/16/1998 | EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof |
09/16/1998 | CN1193357A Oligonucleotide tags for sorting and identification |
09/16/1998 | CN1192930A Contrast medium capable of eliminating in-stomach fluid level false shadow in CT scanning and use method thereof |
09/15/1998 | US5808025 Polypeptide |
09/15/1998 | US5808007 Treating cell proliferative or immunologic disorders |
09/15/1998 | US5808005 Medical diagnosis; vaccines |
09/15/1998 | US5807971 Core with polyoxaalkylene branches |
09/15/1998 | US5807884 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
09/15/1998 | US5807879 Biotinidase-resistant biotinylated compound and methods of use thereof |
09/15/1998 | US5807831 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
09/15/1998 | US5807536 Anatomical imaging with phycocyanins |
09/11/1998 | WO1998039664A1 PROCESS FOR OBTAINING IMAGES AND SPECTRA OF THE EXTRACELLULAR pH BY MAGNETIC RESONANCE WITH EXTRINSINC INDICATORS CONTAINING ?1H OR 19¿F |
09/11/1998 | WO1998039653A1 Methods for producing pure perlecan and other heparan sulfate proteoglycans |
09/11/1998 | WO1998039288A1 Polydentate imines and their metal complexes |
09/11/1998 | WO1998039277A1 Triarylmethyl free radicals as image enhancing agents |
09/11/1998 | WO1998039036A1 X-ray contrast media |
09/11/1998 | WO1998039035A1 Method and compositions for healing tissue defects and inducing hypervascularity in mammalian tissue |
09/11/1998 | CA2282659A1 X-ray contrast media |
09/09/1998 | EP0862432A1 Two-photon upconverting dyes and applications |
09/09/1998 | EP0862420A1 Synthesis of drug nanoparticles by spray drying |
09/09/1998 | CN1192733A Stable reagent for prepn. of radiopharmaceuticals |
09/09/1998 | CN1192698A Prepn. and use of contrast agents |
09/09/1998 | CN1192690A Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
09/09/1998 | CN1192654A Novel embolizing compositions |
09/08/1998 | US5804561 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
09/08/1998 | US5804440 A deoxypolynucleotide encoding heavy chanin immunologlobulin variable region amino acid residue sequence portion of humans monoclonal antibody which is used in immunotherapy and diagnosis |
09/08/1998 | US5804389 Applying a cyanine dye labeling composition to a target site |
09/08/1998 | US5804177 Method of using CD24 as a cell marker |
09/08/1998 | US5804164 Water-soluble lipophilic contrast agents |
09/08/1998 | US5804162 Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients |
09/08/1998 | US5804161 A metal complex containing phosphine group used for diagnostic imaging |
09/03/1998 | WO1998038513A1 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
09/03/1998 | WO1998038204A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
09/03/1998 | CA2282729A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
09/02/1998 | EP0861667A2 Particulate agents |
09/02/1998 | EP0861259A1 Process for producing tungsten clusters |
09/02/1998 | EP0861093A1 Non-invasive localization of a light-emitting conjugate in a mammal |
09/02/1998 | EP0695138A4 Stabilization of voltage sensitive dyes |
09/02/1998 | EP0533898B1 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
09/02/1998 | CN1192160A Chelating polymers as contrast agents for medical imaging |
09/02/1998 | CN1192159A Gas emulsions stabilized with fluorinated ethers having low ostwald coefficients |
09/02/1998 | CN1192128A Coatings for production of hyperpolarized noble gases |
09/01/1998 | US5801229 Radiation sensitizers; antitumor agents |
09/01/1998 | US5801228 Polymeric contrast agents for medical imaging |